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Copyright © 2010 JCBN Summary The obese patients with diabetes or cardiovascular risk factors are associated with
increased risk of colorectal cancer as well as adenomas under the shared pathogenesis related
to atherosclerosis. Here we determined the association between increased arterial stiffness
and colorectal adenomas incorporating parameters including age, gender, waist circumference,
body mass index, lipid profiles, fasting glucose, and blood pressure. Subjects who simulta-
neously underwent colonoscopies and pulse wave velocity (PWV) determinations between July
2005 and September 2006 were analyzed, based on which the subjects were classified into two
groups as patients group with colorectal adenomas (n = 49) and control group (n =2 0 0 )  w i t h
normal, non-polypoid benign lesions or hyperplastic polyps. Uni- and multi-variate analyses
were performed to calculate the odd ratio for colon adenomas. Based on uni-variate analysis,
age, waist circumference, body mass index, heart-femoral PWV (hfPWV), and brachial-ankle
PWV were significantly associated with adenomas (p<0.05) and multiple logistic regression
analysis showed that the heart-femoral PWV, waist circumference, and the levels of LDL-C
were significant risk factor for colorectal adenoma. However, arterial stiffness did not affect
the progression of colon adenoma. The finding that hfPWV, reflecting aortic stiffness, was
increased in patients with colorectal adenomas lead to conclusion that patients who have
prominently increased arterial stiffness can be recommended to undergo colonoscopic exami-
nations and at the same time we also recommend counseling about the risk for atherosclerosis
in those who have colorectal adenomas.
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Introduction
Many researchers have speculated that cancer may share
several risk factors with cardiovascular disease [1–4]. That
is, insulin resistance associated with metabolic syndrome is
one of well-known risks for cardiovascular disease and
cancer [5] and obesity has been linked to an increased risk
for colorectal cancer and adenomas [6–11]. Therefore, an
understanding of the risk factors for colorectal cancer and
adenomas may guide the development of strategies targeted
toward prevention.
Pulse wave velocity (PWV) reflecting arterial stiffness
is a non-invasive method for assessing the early stages of
atherosclerosis [12]. Aortic stiffness is assessed by mea-
suring the carotid-femoral pulse wave velocity (cfPWV).
The heart-femoral pulse wave velocity (hfPWV) is also
positively correlated with the cfPWV [13]. The brachial-Y.J. Lim et al.
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ankle PWV (baPWV) reflects the stiffness of both central
elastic and peripheral muscular arteries, and correlates
positively with conventional cfPWV [12, 14]. Both baPWV
and hfPWV are associated with cardiovascular risk factors
as well as the metabolic syndrome [14, 15].
Since a number of reports have shown that obesity and
cardiovascular risk factors are associated with colorectal
cancer as well as adenomas [6–10, 16], in the current study,
we determined the association between parameters related




Nine hundred two patients underwent colonoscopic
examinations for screening purposes for colon adenomas or
cancer during the study period. This study was conducted
prospectively after approving Instutional Review Board
(IRB of Dongguk University Ilsan hospital, Goyang, Korea).
The study was in accordance with the ethical guidelines of
the Helsinki Declaration (1989). The subjects completed a
clinic survey to determine their eligibility. Six hundred
fourteen patients were excluded because of a preference not
to participate, inadequate eligibility, or the below exclusion
criteria. The exclusion criteria included a history of colon
cancer, prior colon surgery, prior colorectal polypectomy, a
history of a cerebrovascular accident, a colon examination
(sigmoidoscopy, colonoscopy, or barium enema) within
the previous 5 years, a history of hypertension, diabetes
mellitus, or hyperlipidemia which was being treated with
medication, other chronic medical illnesses. Thirty-nine
patients were dropped out because they did not undergo
PWV determinations or omitted blood sampling. Finally 249
subjects were enrolled in the present investigation. The
study subjects were divided into the following two groups
according to the premalignant potential of the lesion; one
was the case group had histologically-confirmed colorectal
adenomas including tubulovillous adenomas or serrated
adenomas and the other was the control group showing
normal colonoscopic findings and non-polypoid benign
lesions such as non-specific colitis or histologically-
confirmed sporadic hyperplastic polyps.
Laboratory assay and measurement
The fasting glucose and lipid profiles were measured by
the hexokinase method (Roche Diagnostics, Indianapolis, IN)
on a Hitachi 7600 automated chemistry analyzer (Hitachi,
Tokyo, Japan). The body mass index (BMI) was calculated
as the weight in kilograms divided by the height in meters
squared. The waist circumference (cm) was measured at the
mild point between the lower margin of the ribs and the
upper margin of the iliac crest during minimal respiration.
The measurement of pulse wave velocity (PWV)
The PWV (cm/sec) was measured using an automatic
waveform analyzer (VP-2000; Colin Co., Komaki, Japan),
which simultaneously records pulse waves, blood pressure,
electrocardiogram (ECG), and heart sounds. Cuffs with an
oscillometric pressure sensor were applied to the extre-
mities, ECG electrodes were attached to both wrists, and
a microphone for phonocardiography was placed at the
second intercostal space on the left border of the sternum.
Tonometric sensors were placed on the left common carotid
and left femoral arteries. Pulse waves were recorded when
the carotid and femoral pulse waves, ECG, and phono-
cardiogram were stable. Pulse waves were stored for a
sampling time of 10 s with automatic gain analysis and
quality adjustment. Recordings were done two times con-
secutively. Values at the second recording were used to
eliminate error caused by physical stress. The wave form
analyzer automatically determines the time intervals between
the following: the second heart sound and the dicrotic notch
of the carotid pulse (ΔThc); the foot of the carotid pulse and
the foot of the femoral pulse (ΔTcf); and the foot of the
brachial pulse and the foot of the ankle pulse (ΔTba). The
sum of ΔTcf and ΔThc is the time for pulse waves to travel
from the heart (aortic orifice) to the femoral artery (ΔThf).
Also, the wave form analyzer automatically determines the
distances between the two recording sites on the basis of the
subject’s height using the following formulas: the distance
from the heart to the femoral artery (Lhf) = 0.5643 × height
(cm) – 18.381; and the distance from the brachium to the
ankle (Lba) = 0.5934 × height (cm) + 14.4014. PWVs were
calculated automatically according to the following equa-
tions: hfPWV = Lhf/ΔThf; and baPWV = Lba/ΔTba [13, 14].
For the analysis, the baPWV was used as the mean value
of the right and left sides. To assess the reproducibility of
the PWVs, two different observers measured the PWVs
repeatedly in 30 consecutive subjects. The first observer
measured the PWVs twice at intervals ≥5 min; after an
additional interval of ≥5 min, the second observer measured
the PWVs once. At each measurement of PWVs, the cuffs
were wrapped again. Tonometric sensors and a microphone
for phonocardiography were also positioned again. The
Pearson’s correlation coefficients for intra-observer re-
producibility of the hfPWV and baPWV were r =0 . 9 1 2
and r = 0.976, respectively. The corresponding coefficients
of variation were 4.5% and 2.6%, respectively. The
Pearson’s correlation coefficients for inter-observer repro-
ducibility of hfPWV and baPWV were r = 0.802 and
r = 0.972, respectively. The corresponding coefficients of
variation were 5.8% and 3.3%, respectively [17].
Colonoscopy
Colonoscopic examinations were performed by one
experienced endoscopist who had performed >40,000Arterial Stiffness in Colorectal Adenoma
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colonoscopies following bowel preparation with colonlyte
(4 l/274.31 g; consisting of polyethylene glycol [3350.236 g],
sodium bicarbonate [6.74 g], NaCl [5.86 g], sodium sulfate
[22.74 g], and potassium chloride [2.97 g]). The colono-
scopic examination was performed up to the cecal end or
terminal ileum. An advanced adenoma was defined as ≥1c m
in estimated diameter (the largest size was used for multiple
adenomas), containing >25% villous features, high grade
dysplasia, or >3 adenomas.
Statistics
Statistical analysis was performed using the chi-squared
test for comparison of discrete variables, such as gender, and
the t test was used for comparison of continuous variables,
such as age, waist circumference, BMI, lipid profiles, fasting
glucose, blood pressures, and PWVs. The continuous vari-
ables measured in this study are expressed as the mean ±
standard deviation. Multivariate analysis was performed
using entered multiple logistic regression (p<0.3). Age, BMI,
waist circumference, total cholesterol, low density lipo-
protein-cholesterol (LDL-C), fasting glucose, systolic blood
pressure, hfPWV, and brachial-ankle PWV (baPWV) were
included as independent variables in a multiple regression
model. For each variable, the odds ratio (OR) and 95% con-
fidence interval (CI) are given. We examined the effects of
confounding variables on the risk of colon adenomatous
polyps with the Wald test for coefficient variables predicting
risk at a significance level of 0.05. A two-tailed p value
<0.05 was considered statistically significant. All analyses
were performed with SPSS, version 12.0 for Windows
(SPSS, Inc., Chicago, IL).
Results
Two hundred forty-nine subjects were enrolled in the
present investigation (158 males and 91 females with a
mean age of 51.8 ± 7.9 years). Uni-variate analysis of the
risk for colorectal adenomas among the clinical factors,
including age, gender, anthropometric parameters, lipid
profiles, fasting glucose, blood pressure, and PWV, are
shown in Table 1. As anticipated, age, male gender, waist
circumference, BMI, hfPWV, and mbaPWV were signifi-
cantly associated with colon adenomas (Table 1). However,
no differences were identified for other factors such as lipid
profiles, fasting glucose, and blood pressure. Based on the
multiple logistic regression analsis of whole 249 patients,
the hfPWV, but not the mbaPWV, was a significant risk
factor (OR, 1.005; 95% CI, 1.001–1.008; p = 0.02) and waist
circumference was a borderline significant risk factor (OR,
1.063; 95% CI, 1.000–1.133; p = 0.05) for adenomas
(Table 2). When multiple regression analysis was done in
patients with advanced colon adenoma, which was defined
as ≥1 cm in estimated diameter, containing >25% villous
features, high grade dysplasia, or >3 adenomas irrespective
of adenoma size, only age was a borderline significant
risk factor (OR, 1.243; 95% CI, 0.984–1.571; p = 0.06).
(Table 3), signifying that though hfPWV contributed to
colon adenoma, but not major factor.
Discussion
The incidence of colorectal cancer and adenomas is on
very rise tendency because of the increase in the number of
elderly group and the steeply increased prevalence of
Table 1. Baseline demographic, laboratory, and anthropometric characteristics of controls and adenomas with
statistical difference between groups
*BMI; body mass index, †LDL-C; low density lipoprotein-cholesterol, ‡HDL-C; high density lipoprotein-
cholesterol, §hfPWV; heart-femoral pulse wave velocity, ∥baPWV; brachial-ankle pulse wave velocity.
Control (n = 200) Adenoma (n = 49) p value
Age (years) 50.10 ± 9.74 53.92 ± 10.55 0.02
Male gender (n) 119 (59.5%) 39 (79.6%) <0.01
BMI (kg/m2)* 24.1 ± 2.6 25.3 ± 2.5 0.01
Waist circumference (cm) 80.36 ± 12.46 87.11 ± 9.67 <0.01
Total cholesterol (mg/dl) 199.8 ± 37.3 191.4 ± 34.1 0.16
Triglycerides (mg/dl) 148.0 ± 32.1 153.73 ± 36.3 0.81
LDL-C (mg/dl)† 133.3 ± 36.0 127.1 ± 30.8 0.28
HDL-C (mg/dl)‡ 56.1 ± 15.6 52.6 ± 15.9 0.18
Fasting glucose (mg/dl) 66.87 ± 23.67 60.02 ± 23.29 0.08
hfPWV (cm/sec)§ 840.92 ± 151.11 931.31 ± 178.31 <0.01
baPWV (cm/sec) ∥ 1316.55 ± 239.97 1436.94 ± 262.79 <0.01
Systolic BP (mmHg) 125.42 ± 18.40 131.13 ± 24.49 0.09
Diastolic BP (mmHg) 74.19 ± 8.72 74.09 ± 8.20 0.95Y.J. Lim et al.
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obesity worldwide [18–19]. Similarly, the risk for cardio-
vascular diseases and metabolic syndrome also increased,
based on the fact that these diseases share common causality
and can be explained by inflammation, oxidative stress, and
insulin resistance as for underlying pathogenesis [10]. In
fact, recent reports have suggested that components of
metabolic syndrome, obesity, or diabetes have a positive
association with colorectal cancer or adenomas [6–10, 16]
and several studies have provided evidence that obesity or
diabetes are associated with colorectal cancer [6–10]. As
result, a positive correlation between atherosclerotic lesions
and adenomatous polyps was found [20]. In this study, we
focused on the association between PWVs and colorectal
adenomas because many studies have examined the relation-
ship between cardiovascular risk factors and colorectal
adenomas [6–10] and we are very proud that our study might
be the first investigation focusing on the association between
arterial stiffness and colorectal adenomas.
Arterial stiffness plays an important role in the develop-
ment of atherosclerosis, during which PWV is known to be
an indicator of arterial stiffness and a marker of vascular
damage [12]. Several studies have demonstrated that PWV
is very useful for the diagnosis of atherosclerotic cardio-
vascular diseases [12]. Previous studies [12–13] have
demonstrated that PWV is associated with hypertension,
diabetes mellitus, hyperlipidemia, obesity, and smoking and
we can add more evidence that PWV can be adopted as
one of contributing parameters in predicting the risk of
colorectal adenoma and contributing factor in adenoma
generation. We examined the effects of confounding vari-
ables on the risk of colon adenomatous polyps through the
OR, 95% CI, and Wald test for coefficient variables pre-
dicting risk at a level of significance of 0.05. Although old
age, male gender, obesity-related markers, and diabetes are
well-known risk factors for colon adenomas, no differences
were identified as a function of lipid profiles, fasting
glucose, and blood pressure in present investigation.
Although the OR of hfPWV is 1.005, hfPWV had a signifi-
cant contributing influence on the risk of colon adenoma
based on the Wald test and only hfPWV had an effect on the
risk for colon adenoma by the OR, CI, and Wald test. Due to
small in numbers of advanced adenomatous polyps, 11
cases, limitation exists in documenting the exact risk factors
for advanced polyps. Only age is a borderline risk factor
for advanced colon adenomas. Though we excluded persons
diagnosed with hypertension, diabetes mellitus, and hyper-
tension who were treated with medications, a limitation of
our study was that lifestyle risk factors such as exact
amounts of alcohol consumption and cigarette smoking,
objective assessment of physical activity, and component
of diet were not calculated as confounding variables.
While cfPWV is an established method for measuring
the PWV, a simpler method of measuring the baPWV and
hfPWV has recently become available. Accumulated data
indicate that determination of the baPWV and hfPWV may
be similar to the cfPWV [12]. In contrast to the hfPWV, the
baPWV includes peripheral components of the arterial tree.
We have shown herein that the hfPWV is strongly associated
with colorectal adenomas after adjusting for confounding
factors, indicating that central arterial stiffness is associated
with colorectal adenomas. Waist circumference was shown
to be a borderline significant risk factor for adenomas. Both
hfPWV and baPWV, indicating very early cardiovascular
risk factors, and waist circumference, indicating central
obesity, are associated with colon adenomas. We assumed
that colorectal adenomas, central obesity, and very early
Table 2. Odd ratio drawn from multiple logistic regression
analysis between contributing parameters and colon
adenoma
*hfPWV; heart-femoral pulse wave velocity, †baPWV; brachial-





Waist circumference 1.063 (1.000–1.133) 0.05
hfPWV* 1.005 (1.001–1.008) 0.02
baPWV† 1.000 (0.997–1.002) 0.71
Age 1.002 (0.948–1.055) 0.95
Body mass index 0.960 (0.780–1.182) 0.7
Total cholesterol 0.974 (0.932–1.018) 0.25
LDL-C‡ 0.996 (0.941–1.055) 0.05
Fasting glucose 1.015 (0.990–1.041) 0.24
Systolic BP 1.010 (0.990–1.030) 0.33
Table 3. Odd ratio drawn from multiple logistic regression
analysis between contributing paramaetrs and advanced
colon adenoma*
*Advanced colon adenoma defined as “≥1 cm in estimated diameter,
containing >25% villous features, high grade dysplasia, or >3
adenomas irrespective of adenoma size”; †hfPWV; heart-femoral




Age 1.243 (0.984–1.571) 0.06
weight 1.001 (0.953–1.052) 0.96
Waist circumference 0.964 (0.782–1.188) 0.73
Body mass index 1.082 (0.527–2.222) 0.83
Total cholesterol 0.981 (0.905–1.063) 0.63
Fasting glucose 1.036 (0.952–1.126) 0.41
hfPWV† 1.007 (0.997–1.016) 0.16
baPWV‡ 0.998 (0.994–1.001) 0.24Arterial Stiffness in Colorectal Adenoma
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cardiovascular risk factor were clustered in the same
individual and these disease entities had the underlying same
etiology in common.
In conclusion, patients who have prominently increased
arterial stiffness can be recommended to undergo colono-
scopic examinations and at the same time we also recom-
mend counseling about the risk for atherosclerosis in those
who have colorectal adenomas. However, more large sized
analysis will be required to draw more solid guideline for
colon adenoma in patients with high risk of atherosclerosis.
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